Prolactin, LH, TSH, T3 and T4 in patients with urogenital carcinomas.
Serum level of peptide hormones LH, FSH, TSH and prolactin have been measured in patients with urogenital tumor. In this randomized study we found a frequent elevation of TSH and prolactin, which did not correlate. Increased serum level of TSH was confirmed to be without any elevation of serum T3 and T4. In some of these patients ectopic production of peptides may account for this abnormality. Systemic change of peptides in elderly patients, however, must be taken into consideration as well.
D000230:Adenocarcinoma / Q000097:blood; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D011388:Prolactin / Q000097:blood*; D013736:Testicular Neoplasms / Q000097:blood; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D001749:Urinary Bladder Neoplasms / Q000097:blood; D014565:Urogenital Neoplasms / Q000097:blood*
D014284:Triiodothyronine; D011388:Prolactin; D007986:Luteinizing Hormone; D013972:Thyrotropin; D013974:Thyroxine